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Each month, Chemistry & Biology Select highlights a selection of research reports from the recent
literature. These highlights are a snapshot of interesting research done across the field of chemical
biology. This month’s Select highlights a community-driven effort to improve drug sensitivity pre-
diction algorithms, a report that XNAs can act as catalysts, and the role of galactolipids in systemic
acquired resistance in plants.The image illustrates the global nature of the
efforts that went into the NCI-DREAM project
to assess performance of drug sensitivity
prediction algorithms. The circles represent the
location of the research groups that submitted
their methods for the assessment. Image
courtesy of the NCI-DREAM Challenge
organizers.Community with Big DREAMs
One of the most remarkable developments in biomedicine over the last decade
is the dramatic increase in speed and reduction in cost at which we can
generate large amounts of genomic, epigenomic, and proteomic information.
For example, the cost of whole genome sequencing is now at the level of a
few thousand dollars per genome, making genome sequencing for routine clin-
ical applications close to reality. The combined use of genomic, epigenomic,
and proteomic information for individual patients enables the application of pre-
cision medicine approaches and tailored treatment options to fit each patient’s
unique situation and circumstances.
Before precision medicine becomes a clinical norm, however, there is a need
to develop better understanding of how to use the large amounts of data com-
ing out of these analyses to predict how a given drug will perform given the
genomic context of a patient. Development of drug sensitivity prediction algo-
rithms is an active field of research aimed at addressing this need. Recently, the
National Cancer Institute and the Dialogue onReverse Engineering Assessment
andMethods (DREAM) project came together to provide unbiased analysis and
assessment of 44 drug sensitivity prediction algorithms. The effort lasted
5 months and involved 127 researchers across the globe. Each group behind
the 44 algorithms was provided with access to DNA copy number variation,
transcript expression, mutations, DNA methylation, and protein abundance data for 53 breast cancer cell lines. They were
also provided with dose-response data to 28 drugs for 35 of these cells lines and asked to predict how the remaining 18 cells
lines will respond to the same group of compounds. The methods were ranked based on how well they performed in predict-
ing drug sensitivity for all cell lines and compounds tested. Some general observations about the performance of these
methods are that modeling nonlinearities in the data in general improves the performance, as does including learning weights
for the input data, and prior knowledge, such as information about biological pathways. It is exciting to see the community
coming together in this way and generating a valuable resource for further development of computational approaches for pre-
dicting drug sensitivity.
Costello et al. (2014). Nat. Biotechnol. Published online June 1, 2014. http://dx.doi.org/10.1038/nbt.2877.Introducing XNAzymes
In the world of nucleic acids, the precedent that both DNA and RNA can serve not only to store and transmit genetic informa-
tion but to catalyze chemical transformations has been well established. Catalytic RNA and DNA molecules, known as
RNAzymes and DNAzymes, respectively, can facilitate a number of different reactions and can be evolved to acquire new
functions. AlthoughRNAzymes exist in nature, all DNAzymes reported so far have beenmanmade. Nonetheless, both classes
of nucleic acid enzymes are of practical technological interest and of more fundamental interest to enzymologists and those
working on questions related to origin of life.
Xeno nucleic acids, XNAs, are synthetic genetic polymers in which ribose and deoxyribose that form RNA and DNA
backbones, respectively, are replaced by other types of linkages. This results in molecules that are able to store information,
evolve under laboratory conditions, fold into well-defined structures, and bind ligands, making them very similar to naturally
occurring DNAs and RNAs. However, whether XNAs can catalyze reactions has not been previously reported. Taylor et al.
now report that XNAs, made of four different scaffolds with arabinose (ANA), fluoro-arabinose (FANA), cyclohexenol
(CeNA), or 1,5-anhydrohexitol (HNA) in the backbone, are enzymes that perform functions of RNA endonuclease, RNA
ligase, and XNA ligase. Some of the XNAzymes described have rates of reaction close to that seen in DNAzymes and
RNAzymes, but some are not as active and their reactions are significantly slower, albeit faster than when no catalyst isChemistry & Biology 21, December 18, 2014 ª2014 Elsevier Ltd All rights reserved 1597
Chemistry & Biology
Selectused. The authors offer an intriguing explanation for this effect: what if these ‘‘slower’’ XNAzymes are more catalytically active
under nonphysiological conditions and thus might be important for supporting the emergence of life under extraterrestrial
and/or prebiotic conditions. A provocative thought, indeed!
Taylor et al. (2014) Nature. Published online December 1, 2014. http://dx.doi.org/10.1038/nature13982.New research shows that
monogalactosyldiacylglycerol (MGDG) and
digalactosyldiacylglycerol (DGDG) play a role in
plant systemic immunity. MGDG and DGDG
were found to have different roles and affect
levels of different signaling molecules involved
in mediating the systemic immune response.
Image courtesy of Pradeep and Aardra
Kachroo.
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As well as being a mouthful to pronounce, monogalactosyldiacylglycerol
(MGDG) and digalactosyldiacylglycerol (DGDG) are plant galactolipids espe-
cially abundant in chloroplast membranes. Humans care about them because
they are to a great extent responsible, due to their anti-inflammatory and anti-
cancer activities, for the claim that green leafy vegetables are one of the
healthiest food choices. The reasons why plants invest in producing large quan-
tities of MGDG and DGDG have to do with the specific physicochemical prop-
erties that their presence imparts on the membranes in which they are found.
But that’s not where their roles end, as galactolipids have been associated
with systemic acquired resistance (SAR), a process in plants that plays a role
analogous to the innate immune system in animals; however, the mechanistic
details have not been well established.
In their recent work, Gao and colleagues explore the biochemical basis for the
link between the two galactolipids, MGDG and DGDG, and SAR using wild type
and transgenic plants in which production of MGDG and DGDGwas interrupted
by mutating enzymes critical for MGDG and DGDG biosynthesis, respectively.
The authors present evidence that the two galactolipids have nonredundant
roles in regulating SAR, as they contribute at different steps in the SAR process.
MGDG is found to function through regulation of a plant’s ability to produce two
components of the SAR signaling arsenal: glycerol-3-phosphate (G3P) and
azelaic acid (AzA). On the other hand, DGDG seems to be directly linked toearly SAR steps and the levels of two other signaling molecules, nitric oxide (NO) and salycilic acid (SA). Digging even deeper,
Gao et al. show that a feature of DGDG that is essential for normal SAR function is the axial hydroxyl group at C4 of DGDG
galactose. Overall, SAR is a complex process that involves multiple signaling pathways, signaling molecules, and now
galactolipids.
Gao et al. (2014) Cell Rep. Published online November 26, 2014. http://dx.doi.org/10.1016/j.celrep.2014.10.069.
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